Výsledky vyhledávání

Akademický článek

Impact of physiotherapy access on health-related quality of life following hip fracture: an observational study on 30 752 hip fractures from the Norwegian Hip Fracture Register 2014–2018

Autor: Kristin Taraldsen, Jan-Erik Gjertsen, Bård Uleberg, Eva Stensland, Cato Kjærvik, Odd Søreide

Publikováno v: BMJ Open, Vol 14, Iss 6 (2024)

Objectives The main objective of this study was to investigate the characteristics of patients receiving private community physiotherapy (PT) the first year after a hip fracture. Second, to determine whether utilisation of PT could improve health-rel

Externí odkaz: https://doaj.org/article/3550878eef034a8d8c0d437689fd8044

Zobrazit plný text záznamu

Akademický článek

Waiting time for hip fracture surgery: hospital variation, causes, and effects on postoperative mortality: data on 37,708 operations reported to the Norwegian Hip fracture Register from 2014 to 2018

Autor: Cato Kjaervik, Jan-Erik Gjertsen, Lars B. Engeseter, Eva Stensland, Eva Dybvik, Odd Soereide

Publikováno v: Bone & Joint Open, Vol 2, Iss 9, Pp 710-720 (2021)

Aims: This study aimed to describe preoperative waiting times for surgery in hip fracture patients in Norway, and analyze factors affecting waiting time and potential negative consequences of prolonged waiting time. Methods: Overall, 37,708 hip fract

Externí odkaz: https://doaj.org/article/56418fe2b73b45d6a72fa522a968af8a

Zobrazit plný text záznamu

Akademický článek

Hip fracture treatment in Norway: Deviation from evidence-based treatment guidelines: data from the Norwegian Hip Fracture Register, 2014 to 2018

Autor: Cato Kjærvik, Eva Stensland, Hanne Sigrun Byhring, Jan-Erik Gjertsen, Eva Dybvik, Odd Søreide

Publikováno v: Bone & Joint Open, Vol 1, Iss 10, Pp 644-653 (2020)

Aims: The aim of this study was to describe variation in hip fracture treatment in Norway expressed as adherence to international and national evidence-based treatment guidelines, to study factors influencing deviation from guidelines, and to analyze

Externí odkaz: https://doaj.org/article/35f9c54c25a34dffb2fd4e1bf3bc3e4b

Zobrazit plný text záznamu

Akademický článek

In vitro and in vivo characterization of the non-peptide NK3 receptor antagonist SB-223412 (talnetant): potential therapeutic utility in the treatment of schizophrenia.

Autor: Dawson LA; Psychiatry Centre of Excellence for Drug Discovery, GlaxoSmithKline, Essex, UK. Lee.A.Dawson@gsk.com, Cato KJ, Scott C, Watson JM, Wood MD, Foxton R, de la Flor R, Jones GA, Kew JN, Cluderay JE, Southam E, Murkitt GS, Gartlon J, Pemberton DJ, Jones DN, Davies CH, Hagan J

Publikováno v: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2008 Jun; Vol. 33 (7), pp. 1642-52. Date of Electronic Publication: 2007 Aug 29.

Zobrazit plný text záznamu

Akademický článek

Pharmacological profile of antipsychotics at monoamine receptors: atypicality beyond 5-HT2A receptor blockade.

Autor: Wood MD; Psychiatry Centre for Excellence in Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, UK. martyn.wood-1@gsk.com, Scott C, Clarke K, Cato KJ, Patel N, Heath J, Worby A, Gordon L, Campbell L, Riley G, Davies CH, Gribble A, Jones DN

Publikováno v: CNS & neurological disorders drug targets [CNS Neurol Disord Drug Targets] 2006 Aug; Vol. 5 (4), pp. 445-52.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání